A recent study points to a key bone-strengthening mechanism at work in the body, which could be targeted to treat the ...

A newly discovered receptor switch that boosts bone growth could transform how we treat osteoporosis, by stimulating the body’s own bone-building machinery using a targeted drug and even mechanical ...

In a world where an aging population faces increasing health challenges, a silent epidemic is quietly eroding the quality of life for millions. Osteoporosis affects one in three women and one in five ...

Osteoporosis is typically treated with orally administered drugs, which may take up to a year to have a noticeable effect. A new injectable hydrogel, however, is claimed to drastically boost bone ...

Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab) ...

Shot of a young male doctor talking with older male patient. Source: Getty Images The researchers used the Baltimore Longitudinal Study of Aging, a prospective cohort study of community-dwelling older ...

LOS ANGELES, Dec 15 (Reuters) - Amgen Inc. said on Friday that results from a mid-stage trial of its experimental drug denosumab continue to show that it works at least as well as current therapies to ...

A comprehensive review by the International Osteoporosis Foundation (IOF) Bone and Cancer Working Group detailing the often underrecognized impact of modern anti-cancer treatments on bone health.